Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] AREA[BasicSearch] Hematologic Diseases
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 … 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 Next Last
Active, not recruiting
Conditions: Benign and Malignant Hematologic Diseases
Intervention: Protease Inhibitors
Terminated
Conditions: Anemia, Sickle Cell
Intervention: Skin Biopsy, Blood Draw & Sample
Completed
Conditions: Hematologic Diseases; Bacteremia Sepsis
Intervention: DRAST, Current Standard Method
Recruiting
Conditions: Bone Marrow Failure Syndromes; Erythrocyte Disorder; Leukocyte Disorder; Hemostasis; Blood Coagulation Disorder; Sickle Cell Disease; Dyskeratosis Congenita; Diamond-Blackfan Anemia; Congenital Thrombocytopenia; Severe Congenital Neutropenia; Fanconi Anemia
Completed
Conditions: Hematologic Diseases
Completed
Conditions: Hematologic Diseases
Intervention: Touch-massage
Completed
Conditions: Febrile Neutropenia
Intervention: Ciprofloxacin, Cefepime
Recruiting
Conditions: Hematological Disorders
Active, not recruiting
Conditions: Hematologic Disorders
Intervention: Miltenyi CliniMACS® CD34 Reagent System
Completed
Conditions: Advanced Hematological Disorders
Intervention: ORH-2014, ORH-2014
Completed
Conditions: Hematologic Diseases
Intervention: Blood Draw, Skin Biopsy
Recruiting
Conditions: Leukemia
Recruiting
Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Non-Neoplastic Hematologic and Lymphocytic Disorder
Intervention: Supportive Palliative Care, Clinical Management, Best Practice, Allogeneic Hematopoietic Stem Cell Transplantation, Questionnaire Administration, Quality-of-Life Assessment, Survey Administration
Recruiting
Conditions: Malignant Hematologic Disorder
Intervention: No Intervention
Completed
Conditions: Hematologic Disease
Active, not recruiting
Conditions: Hematologic Diseases; Healthy Volunteers
Intervention: Isolation Of Genomic DNA
Recruiting
Conditions: Hematopoietic Stem Cell Transplantation; Haplo-identical Donor; Cord Blood; Hematologic Diseases
Intervention: Haplo-SCT, Haplo-cord SCT
Completed
Conditions: Hematologic Diseases
Intervention: Shanghai Workers
Completed
Conditions: Hematological Neoplasms; Hematopoietic Stem Cell Transplantation
Intervention: Busulfex, Fludarabine, ALemtuzumab
Recruiting
Conditions: Hematologic Diseases
Recruiting
Conditions: Bone Marrow Transplant; Sickle Cell Disease; G-CSF
Recruiting
Conditions: Non-Malignant Hematologic Disorders
Intervention: Melphalan, Thiotepa, Clofarabine, Fludarabine, Anti-Thymocyte Globulin (Rabbit) (Thymoglobulin®), CliniMACS Reagents
Completed
Conditions: Hematological Diseases
Intervention: Allogeneic Transplant Conditioning
Active, not recruiting
Conditions: Chronic Myeloid Leukemia; Chronic Lymphocytic Leukemia; Myelodysplastic Syndrome; Chronic Thrombocytopenia; Hodgkin Disease
Intervention: Study Questionnaire, SF-36 Questionnaire
Recruiting
Conditions: Malignant Hematologic Neoplasm
Completed
Conditions: Hematologic Diseases; Secondary Immune Deficiency
Recruiting
Conditions: Refractory or Relapsed Lymphoid Haemopathy
Intervention: Sequential Packaging (SET), Transfusion Graft, Prevention Of GVHD, Care Supports, Lymphocyte Injection Of Prophylactic Donor (PDLI)
Recruiting
Conditions: Hematologic Diseases
Intervention: Data Collection
Unknown status
Conditions: Blood Disorders
Intervention: Fecal Microbiota Transplantation
Completed
Conditions: Severe Neutropenia; Thrombocytopenia; Chemotherapy; Blood Dyscrasia Patients
Intervention: Supragingival Irrigators Containing Chlorhexidine
Completed
Conditions: Oncologic Disorders; Hematologic Diseases
Intervention: Riboflavin+UV RBC, Irradiated RBC
Terminated
Conditions: Hematologic Malignancies
Intervention: Campath 1H, Fludarabine, Stem Cell Transplant, Total Body Irradiation (TBI), FK506 (Tacrolimus) Or Cyclosporine
Completed
Conditions: Hematologic Disease; Solid Organ Transplantation
Unknown status
Conditions: Chronic Lymphoid Leukemia
Intervention: Cholecalciferol, Oleum Neutralicum
Completed
Conditions: Hematologic Diseases
Intervention: Chemotherapy And Blood Stem Cell Transplantation
Active, not recruiting
Conditions: Leukemia
Completed
Conditions: Hematological Malignancy; Bone Marrow Failure Syndrome
Intervention: Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders, Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders, Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders
Terminated
Conditions: Hematologic Diseases
Intervention: G-CSF, GM-CSF
Recruiting
Conditions: Multiple Myeloma; Lymphoma; Bone Marrow Transplantation; Neoplasms; Hematologic Diseases; Leukemia, Myeloid
Intervention: Family Caregiver Ambassador Support
Recruiting
Conditions: Hematologic Neoplasms
Intervention: Mind-body Medicine Group Program
Recruiting
Conditions: Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Ann Arbor Stage I Burkitt Lymphoma; Ann Arbor Stage I Non-Hodgkin Lymphoma; Ann Arbor Stage II Burkitt Lymphoma; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Lymphoblastic Lymphoma; Mantle Cell Lymphoma; Myelodysplastic Syndrome; Myelofibrosis; Pancytopenia; Plasma Cell Myeloma; Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Ann Arbor Stage II Non-Hodgkin Lymphoma; Ann Arbor Stage III Burkitt Lymphoma; Ann Arbor Stage III Non-Hodgkin Lymphoma; Ann Arbor Stage IV Burkitt Lymphoma; Ann Arbor Stage IV Non-Hodgkin Lymphoma; High Risk Acute Myeloid Leukemia; Progressive Disease; Refractory Anemia
Intervention: Cyclophosphamide, Cyclosporine, Double-Unit Umbilical Cord Blood Transplantation, Fludarabine, Laboratory Biomarker Analysis, Mycophenolate Mofetil, Total-Body Irradiation, Umbilical Cord Blood Transplantation, Thiotepa
Recruiting
Conditions: Hematologic Neoplasm; Neoplasms
Intervention: CC-486
Not yet recruiting
Conditions: Acute Leukemia; Severe Aplastic Anemia; Non-hodgkin Lymphoma; Hodgkin Lymphoma; Kostmann; Diamond Blackfan Anemia; Amegakaryocytic Thrombocytopenia; Sickle Cell Disease; Beta-Thalassemia
Intervention: Alpha Beta Depletion
Completed
Conditions: Hematologic Disease
Intervention: Caphosol, Bicarbonate De Sodium
Unknown status
Conditions: Blood Disease; Platelet Refractoriness; Antibody-mediated Rejection
Intervention: Same Type Infusion Of Main HPA Antigen
Recruiting
Conditions: Neoplasms; Hematologic Neoplasms; Healthy Volunteers
Terminated
Conditions: Acute Leukemias; Burkitt's Lymphoma; Chronic Myelogenous Leukemia
Intervention: Fludarabine, Cyclophosphamide, Total Body Irradiation, Haploidentical Stem Cell Transplant
Not yet recruiting
Conditions: Hematologic Diseases; Chronic Myeloid Leukemia; Acute Myeloid Leukemia; Acute Lymphoid Leukemia; Myelodysplastic Syndromes; Non Hodgkin Lymphoma; Stem Cell Transplant Complications; Chronic Lymphocytic Leukemia
Intervention: No Intervention
Completed
Conditions: Febrile Neutropenia; Hematological Diseases
Intervention: Micafungin Sodium, Itraconazole
Terminated
Conditions: Cutaneous Lymphoma; Other Skin Disorders; Mycosis Fungoides; Cutaneous T-cell Lymphoma
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 … 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 Next Last
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Examples:
97-h-0197
ia0006
actg 076
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
There are three types of studies available in ClinicalTrials.gov:
Observational:
Expanded Access:
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help Topics:
Basic Search:
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Open recruitment status values:
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Studies With Results, or
Studies Without Results
Observational, or
Expanded Access
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
Refine Search:
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
For example:
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.